Self-reported red and processed meat intake has been positively associated with colorectal adenoma and cancer; however, measurement error in self-reported data can attenuate risk estimates, increasing the need for improved exposure assessment methods to better understand this association. A controlled feeding study revealed that urinary 1-methylhistidine and 3-methylhistidine levels were dose-dependently associated with meat intake; our aim was to examine these analytes in relation to colorectal adenoma. Individuals undergoing routine cancer screening by sigmoidoscopy or colonoscopy were recruited for a colorectal adenoma case-control study; participants completed a food frequency questionnaire and a meat questionnaire, and donated urine. Urinary 1-methylhistidine and 3-methylhistidine levels were measured in 131 case-control pairs (age, sex, and smoking matched); odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by logistic regression. Although the mean self-reported red meat intake was higher in cases (59 g/day) than in controls (48 g/day), the mean urinary 1-methylhistidine and 3-methylhistidine levels did not differ by case status (P = 0.72). Neither urinary 1-methylhistidine nor urinary 3-methylhistidine was associated with colorectal adenoma (OR continuous = 0.90, 95% CI: 0.53-1.54; OR continuous = 0.90, 95% CI: 0.69-1.17, respectively). A variable combining self-reported red meat intake with urinary 1-methylhistidine and 3-methylhistidine levels was not associated with colorectal adenoma. Analyzing urine samples from multiple days from 17 individuals revealed intraclass correlations of 0.52 and 0.49 for 1-methylhistidine and 3-methylhistidine, respectively; this variability could result in attenuated risks. Urinary 1-methylhistidine and 3-methylhistidine levels, measured in one sample, were not associated with colorectal adenoma.
Introduction
The role of diet in cancer etiology has been investigated for many years; however, the evidence on specific beneficial or harmful dietary components has been largely inconclusive to date. Most epidemiologic studies rely on self-reported dietary data, which are subject to reporting bias and consequently result in misclassification. Biomarkers of dietary intake are not subject to the same errors associated with self-reported data and they may be able to better characterize true exposures by incorporating multiple factors, such as diet, lifestyle, the environment, and genetics; in addition, biomarkers may shed light on potential mechanisms underlying diet-cancer associations. Currently, however, very few biomarkers of dietary exposures have been identified, and there are no established biomarkers of meat intake.
Despite the inherent difficulties with accurately assessing diet in epidemiologic studies, self-reported red and processed meat intake has been positively associated with colorectal adenoma and cancer, although the risks are modest, and the association between meat and other malignancies is less clear (WCRF/AICR, 2007) . As there are several potential mechanisms linking meat to carcinogenesis, including heterocyclic amines, polycyclic aromatic hydrocarbons, and N-nitroso compounds (Cross and Sinha, 2004) , it is important to further investigate the role of meat in cancer etiology using a more direct measure of exposure.
Both 1-methylhistidine and 3-methylhistidine are present in muscle and, therefore, they are both found in meat. It is known that the majority of urinary 1-methylhistidine is from dietary sources, particularly from meat (Sjolin et al., 1987) , whereas 3-methylhistidine is found in the diet and also presents as a result of muscle catabolism (Lukaski and Mendez, 1980) . A controlled feeding study investigated 1-methylhistidine and 3-methylhistidine as potential biomarkers of meat intake and found a dose-dependent association between meat intake and urinary excretion of 1-methylhistidine and 3-methylhistidine (Cross et al., 2011) . The aim of this study was to investigate urinary 1-methylhistidine and 3-methylhistidine levels in relation to colorectal adenoma.
Methods

Study design
We selected individuals from a case-control study on colorectal adenoma conducted at the National Naval Medical Center (Bethesda, Maryland, USA; Sinha et al., 1999) . To be eligible for the original study conducted between 1994 and 1996, individuals had to be residents of the study area; had to be between 18 and 74 years old; had to have never been diagnosed with Crohn's disease, ulcerative colitis, colorectal neoplasms, or cancer (except nonmelanoma skin cancer); and should have been scheduled to undergo routine colorectal cancer screening. The participation rates in the original study were 84% for adenoma cases and 74% for controls (Sinha et al., 1999) . All participants provided information on demographic factors and diet through a validated food frequency questionnaire (FFQ) that was a modified version of the 100-item Health Habits and History Questionnaire (Smucker et al., 1989) . In addition to the FFQ, participants completed a validated meat questionnaire that captured detailed information about usual meat intake (Cantwell et al., 2004) . Although the FFQ and meat questionnaire were administered B3 months after the screening exam, they asked the participants to record their usual diet during the previous 12 months. Cases were defined as patients who were diagnosed with colorectal adenoma at sigmoidoscopy or colonoscopy, and controls were deemed polyp-free in their distal colon and rectum by sigmoidoscopy.
To be eligible for the present study, participants should have completed an overnight urine collection and have sufficient sample remaining in storage. We identified 131 colorectal adenoma patients with no previous history of rectal bleeding and complete questionnaire data; we matched these patients to an equal number of controls by age (5-year groups), sex, and smoking status (ever or never).
Urine sample collection and analysis
The overnight urine samples were collected under the nonfasting condition, and they were collected B60-90 days after the colorectal cancer screening exam. Further, we obtained urine samples from multiple days from 17 individuals, 10 of whom provided overnight urine samples from three different days (there was a median of 5.3 days between the first and third urine collection) and seven of whom provided overnight urine samples from two different days (a median of 2.0 days apart); these samples were used to assess the variability in 1-methylhistidine and 3-methylhistidine levels. Urinary 1-methylhistidine and 3-methylhistidine levels were measured at SAIC (Frederick, Maryland, USA) using gas chromatography-mass spectrometry and a solid phase extraction method. Cases were placed in batches next to their matched controls, with 36 samples per batch.
Statistical analysis
Means and frequencies for characteristics of the cases and controls were compared and P-values were calculated using t-test for continuous variables and w 2 -test for categorical variables. We calculated Pearson's correlation coefficients for self-reported meat intake variables and urinary 1-methylhistidine and 3-methylhistidine levels among the controls only.
Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by unconditional logistic regression. Models were adjusted for the following covariates: age, sex, education, race, body mass index (BMI), family history of cancer, smoking status, total hours spent in moderate and vigorous physical activity, and fiber intake (g/day). We investigated continuous variables for red meat and white meat (per 10 g/1000 kcals), and for processed meat (per 5 g/ 1000 kcals), as well as the log-transformed urine measures of 1-methylhistidine and 3-methylhistidine. We also analyzed both the self-reported dietary data and the urinary markers categorically, using quartile cutoff points determined from the distribution among the controls.
Finally, we created a meat-exposure index that combined the self-reported dietary data and the urinary markers. We identified a group of individuals who were in the highest quartile of self-reported red meat intake and also in the highest quartile of urinary 1-methylhistidine or 3methylhistidine. In a dichotomous analysis, we determined whether those in this high-exposure group were more likely to have had an adenoma than those who did not fall in the highest quartile for both the self-reported meat consumption data and the urine data. We also examined the combined meat intake-urinary data as a categorical variable in logistic regression models categorizing those who were in both the lowest quartile of the self-reported data and the lowest quartile of the urine data as the referent group, those in the highest quartile of both as the high-exposure group, and the remaining people as the middle category.
Results
Adenoma cases and controls were B57 years old: 77% were male, 48% were never smokers, and 7-8% were current smokers (Table 1) . Both adenoma cases and controls were predominantly non-Hispanic Whites (B86%), with no family history of cancer (B86%) and a mean BMI of 27 kg/ m 2 (Table 1 ). The only observed difference was that adenoma cases consumed more red and processed meats than controls (P = 0.02 and 0.01, respectively).
Urinary excretion of 1-methylhistidine and 3-methylhistidine did not differ between the adenoma cases and controls (P = 0.72; Table 2 ). Although 1-methylhistidine and 3-methylhistidine were correlated with each other (r = 0.60), their correlations with the self-reported meat variables were weaker (Table 3) ; 1-methylhistidine was weakly correlated with red meat, white meat, and processed meat (r = 0.21, 0.18, and 0.21, respectively), but 3-methylhistidine was only correlated with white meat (r = 0.25).
On the basis of self-reported meat intake, there was a suggestive positive association between red meat intake and colorectal adenoma (OR = 1.11, 95% CI: 0.97-1.28/ 10 g/1000 kcal) and a suggestive inverse association between white meat intake and colorectal adenoma (OR = 0.89, 95% CI: 0.78-1.02/10 g/1000 kcal); however, there was no association between processed meat intake and colorectal adenoma (OR = 0.99, 95% CI: 0.90-1.10/ 5 g/1000 kcal; Table 4 ). Neither urinary 1-methylhistidine nor urinary 3-methylhistidine was associated with colorectal adenoma (OR = 0.90, 95% CI: 0.53-1.54; OR = 0.90, 95% CI: 0.69-1.17, respectively; Table 5 ). The addition of red and white meat intakes as covariates in the models for urinary 1-methylhistidine and 3-methylhistidine and colorectal adenoma did not affect the results [1-methylhistidine: OR continuous = 0.90, 95% CI: 0.53-1.53; 3-methylhistidine: OR continuous = 0.94, 95% CI: 0.72-1.22 (data not shown)].
Using the self-reported dietary data and urine data, we created a combined exposure variable. Comparing individuals in the highest quartile of both self-reported red meat intake and urinary 1-methylhistidine level (or 3methylhistidine) with all other individuals did not reveal any associations with colorectal adenoma; we also examined a three-level categorical combined exposure variable and the risk remained null (Table 6 ).
Finally, we examined the variability in 1-methylhistidine and 3-methylhistidine levels by analyzing repeat urine samples from 17 individuals from multiple sample days. The intraclass correlations for 1-methylhistidine and 3-methylhistidine were 0.52 and 0.49, respectively (Figs 1 and 2 ).
Discussion
In our study using a single urine sample, neither urinary 1-methylhistidine nor urinary 3-methylhistidine levels were associated with colorectal adenoma. Combining selfreported meat intake data with the urinary data also failed to reveal any associations with colorectal adenoma. However, a small substudy including 17 individuals identified that these urinary analytes had a level of intraindividual variation that could result in attenuated risk estimates if only one urine sample is analyzed. This study was designed to follow-up the dose-dependent association observed between urinary 1-methylhistidine and 3-methylhistidine levels and meat intake in a controlled feeding study (Cross et al., 2011) , a study suggesting that these urinary analytes could be potential biomarkers of meat intake. Although 3-methylhistidine excretion is also related to muscle mass and catabolism (Lukaski and Mendez, 1980) , several other studies have reported increased urinary excretion of 3-methylhistidine after meat intake (Block et al., 1965; Elia et al., 1980; Lukaski and Mendez, 1980; Huszar et al., 1983) . In contrast, the majority of 1-methylhistidine excreted in the urine is from dietary sources (Sjolin et al., 1987) , and measuring this analyte predicted vegetarian status in a study of 126 individuals (Myint et al., 2000) .
Although we did not observe a significant association between 1-methylhistidine or 3-methylhistidine and colorectal adenoma, the urinary levels of these analytes in this study were in the same range as those previously reported (Cross et al., 2011) , suggesting that the lack of association was not due to low exposure. If a biomarker can capture different data from self-reported data, it could be used to complement selfreported data rather than replace it. We did investigate combining the urinary data with the self-reported dietary data but we were not able to detect any associations in this study. Highest quartile in both red meat and methylhistidine. e Those in the highest quartile of red meat and in the highest quartile of urinary 1-methylhistidine (17 adenoma cases and eight controls) or 3-methylhistidine (nine adenoma cases and nine controls) compared with all others.
Possible explanations for our null results could be the short half-life (B12 h) of 1-methylhistidine and 3-methylhistidine (Sjolin et al., 1987) and the frequency of meat intake (e.g. daily vs. occasionally); therefore, 1-methylhistidine and 3-methylhistidine may be good short-term biomarkers of intake, but insufficient measures for longterm meat intake. Nevertheless, a previous study in freeliving individuals did find a positive correlation (r = 0.77) between 3-methylhistidine and meat intake reported by dietary recall 1 year previously (McKeown-Eyssen et al., 1986) . A small subset analysis conducted within our study on 17 individuals providing multiple urine samples revealed that 1-methylhistidine and 3-methylhistidine levels varied within individuals between sample days, suggesting that one urine sample may not be sufficient to represent usual exposure perhaps because of the variability in the frequency of meat intake. The level of variability we observed in 1-methylhistidine and 3-methylhistidine levels could attenuate risk estimates by a factor of two. Unfortunately, we were unable to determine how many urine samples would be required to adequately assess meat intake from our dataset. Finally, if urinary levels of 1methylhistidine and 3-methylhistidine reflect total meat intake, then our null findings may be the result of the contrasting effects of red compared with white meat on colorectal carcinogenesis; both red meat and processed meats have been positively associated with colorectal adenoma and cancer but white meat has not (WCRF/ AICR, 2007). Urinary 1-methylhistidine and 3-methylhistidine levels will also not address potential mechanisms Urinary methylhistidine and colorectal adenoma Cross et al. 389 relating meat to cancer, such as exposure to heterocyclic amines and polycyclic aromatic hydrocarbons, compounds formed when meat is cooked until it is well done using high-temperature cooking methods.
Limitations of our study included the case-control design, although the use of a precursor lesion lessens some of the associated caveats of this study design, and the small sample size, which limits our ability to detect associations with variable data. There is also a possibility that there was misclassification of controls who underwent a sigmoidoscopy rather than a colonoscopy, although approximately two-thirds of adenomas and cancers arise in the distal colon and rectum within the reach of a sigmoidoscope (Parkin et al., 2002) . Further, the urine samples were collected after the screening procedure and, therefore, individuals may have subsequently changed their diet; however, a previous analysis in the same study population did observe a positive association between urinary mutagenicity, proposed to be linked to meat intake, and colorectal adenoma (Peters et al., 1994) . We must also consider that long-term storage of urine samples may affect the measurement of 1-methylhistidine and 3-methylhistidine levels. In addition to the inherent instability of urinary markers and the small number of samples, it is well-known that FFQ data are associated with some degree of measurement error, which may have biased the results toward the null. One additional specific caveat was the lack of information on menopausal status in this study; however, 73% of the women were over the age of 51 years and were thus likely postmenopausal.
Despite the limitations, this study had several strengths, including the ability to capture two types of exposure data, both self-reported data and those collected using biospecimens. The study also had complete case ascertainment, as all participants were screened, meaning the controls were confirmed to be free from polyps in their distal colon and rectum; finally, as the endpoint studied was a precursor lesion, the chances of behavioral and metabolic changes induced by the presence of cancer were minimized.
Conclusion
Neither urinary 1-methylhistidine nor urinary 3-methylhistidine levels were associated with colorectal adenoma; however, a small substudy revealed considerable intraindividual variability in these urinary analytes. Analyzing these potential urinary markers of meat intake in a single urine sample did not reveal any additional information on the meat and colorectal cancer hypothesis. Our data suggest that future studies on dietary biomarkers in urine should consider collecting multiple urine samples to better characterize exposures.
